assessment tool

FIS2 LIS-A Constructing the first European Framework for teaching and assessing the Italian sign language. LIS-A (LIS Assessment)

FIS2 LIS-A Constructing the first European Framework for teaching and assessing the Italian sign language. LIS-A (LIS Assessment)

Over the last half-century, research on Sign Languages (SL) has advanced significantly, shedding light on how SLs function and providing a valuable foundation for teaching L2 learners. However, this wealth of knowledge from SL linguistics hasn't been effectively incorporated into curriculum design and teaching practices. Despite the publication of supplementary descriptors for sign language competence in the Common European Framework of Reference for Languages (CEFR) in 2018, these descriptors are not tailored to Italian Sign Language (LIS) and need adaptation.

Quality of life in Parkinson’s disease: Italian validation of the Parkinson’s Disease Questionnaire (PDQ-39-IT)

Translation and cross-cultural adaptation of the 39-item Parkinson’s Disease Questionnaire (PDQ-39) to the Italian culture was performed by Oxford University Innovation in 2008, but this version has never been validated. Therefore, we performed the process of validation of the Italian version of the PDQ-39 (PDQ-39-IT) following the “Consensus-Based Standards for the Selection of Health Status Measurement Instruments” checklist. The translated PDQ-39-IT was tested with 104 patients diagnosed with Parkinson’s disease (PD) who were recruited between June and October 2017.

Tools to assess the quality of life in patients with Parkinson’s disease. A systematic review

Introduction
. The clinical, social, and economic implications of Parkinson’s disease (PD) are significant; disability occurs leading to a low quality of life (QoL). Information on the QoL of patients with PD and studies on the relationship between QoL and motor and cognitive function are necessary for both research and clinical use to make informed decisions in healthcare and rehabilitation. The aim of this study was to determine which scales are most used to assess QoL in patients with PD.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma